- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.08. | Earnings Call: Treace Medical übertrifft Q2-Prognosen - Aktie springt um 24 % | - | Investing.com Deutsch | ||
| 07.08. | Treace Medical Concepts GAAP EPS of -$0.24 beats by $0.06, revenue of $45.4M beats by $1.48M | 2 | Seeking Alpha | ||
| TREACE MEDICAL CONCEPTS Aktie jetzt für 0€ handeln | |||||
| 07.08. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.08. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Second Quarter 2026 Financial Results | 413 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 07.08. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 24.07. | Treace Medical Concepts, Inc.: Treace to Report Second Quarter 2026 Financial Results on August 7, 2026 | 2 | GlobeNewswire (USA) | ||
| 18.06. | Treace Medical Concepts, Inc.: Treace Announces First Surgical Case with the HyperPlate XM Dynamic Compression Locking Implant System | 2 | GlobeNewswire (USA) | ||
| 20.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 08.05. | Treace Medical: Aktie steigt nach übertroffenen Quartalszahlen trotz Umsatzminus | 1 | Investing.com Deutsch | ||
| 08.05. | Treace Medical Concepts GAAP EPS of -$0.28 beats by $0.03, revenue of $47.2M beats by $1.15M | 3 | Seeking Alpha | ||
| 08.05. | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports First Quarter 2026 Financial Results | 828 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 24.04. | Treace Medical Concepts, Inc.: Treace to Report First Quarter 2026 Financial Results on May 8, 2026 | 2 | GlobeNewswire (USA) | ||
| 09.04. | Stifel belässt Treace Medical auf 'Halten' mit Kursziel von 3 US-Dollar | 3 | Investing.com Deutsch | ||
| 09.04. | Stifel maintains Hold on Treace Medical stock, $3 target unchanged | 1 | Investing.com | ||
| 09.04. | TREACE MEDICAL CONCEPTS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 07.04. | Treace Medical Concepts, Inc.: Treace Announces First Surgical Cases with the SuperBite Compression Screw System | 336 | GlobeNewswire (Europe) | PONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
| 27.02. | Treace Medical signals 2026 revenue target of $200M-$212M while expanding comprehensive bunion solutions | 4 | Seeking Alpha |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,065 | -6,07 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-K, Current Report | ||
| TANDEM DIABETES | 18,600 | +0,54 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| VERU | 2,710 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| SENSEONICS | 8,000 | -1,84 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,110 | 0,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| VIRIDIAN THERAPEUTICS | 21,000 | +0,96 % | Aktien New York Ausblick: Nasdaq erholt - Comcast-Aufspaltung beflügelt Branche | NEW YORK (dpa-AFX) - Die Anleger dürften den jüngsten Kursrückschlag an der New Yorker Tech-Börse Nasdaq direkt zum Wiedereinstieg nutzen. Im Fokus stehen am Montag die jüngste Entspannung im davor... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,550 | -0,64 % | SINTX Technologies, Inc.: SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement | SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical technologies... ► Artikel lesen | |
| VYOME | 2,250 | +2,27 % | Vyome Holdings, Inc - 8-K, Current Report | ||
| VIVANI MEDICAL | 1,120 | 0,00 % | Vivani Medical, Inc.: Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management | Dosing of the first participant commenced ahead of schedule and was rapidly followed by initial dosing in all trial participants. SLIM-1 trial is a Phase 1, randomized, controlled clinical trial design... ► Artikel lesen | |
| STEREOTAXIS | 1,244 | +3,32 % | Stereotaxis, Inc.: Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates | Robotic catheter revenue surpasses $1M in the quarter, growing 270% sequentiallyFirst GenesisX robotic system purchase by US hospital to be installed this fallMultiple Synchrony digital operating... ► Artikel lesen | |
| VIEMED HEALTHCARE | 7,500 | 0,00 % | VIEMED HEALTHCARE, INC. - 8-K, Current Report | ||
| VIVOS THERAPEUTICS | 0,263 | -0,87 % | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers | ||
| TENON MEDICAL | 5,630 | +0,18 % | Tenon Medical, Inc.: Tenon Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement | LOS GATOS, CA / ACCESS Newswire / August 24, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic... ► Artikel lesen | |
| SEASTAR MEDICAL | 3,180 | 0,00 % | SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates | Added 3 top-rated children's hospitals to QUELIMMUNE- pediatric acute kidney injury (AKI) customer base, increasing net revenue 82% versus second quarter 2025 Advanced enrollment in the NEUTRALIZE-AKI... ► Artikel lesen |
TREACE MEDICAL CONCEPTS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 4,810 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TREACE MEDICAL CONCEPTS INC finden Sie auf Wallstreet Online.